Myolex
MA - BrooklineBiotechnology
Focus: Myolex is an early-stage biotech company focused on non-invasive electrical impedance myography for diagnosing and monitoring myopathies. Founded in 2023 and based in Brookline, MA, the company is pre-commercial with minimal public profile.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Myolex
AI assessmentNot HiringNo open roles listed right now. Follow Myolex to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Electrical Impedance Myography
MyopathyClinical Trials (1)
NCT07502989Muscle Health Measurements Using Electrical Impedance Myography
N/AHelp build intelligence for Myolex
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.